5VXA
Structure of the human Mesh1-NADPH complex
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 22-BM |
Synchrotron site | APS |
Beamline | 22-BM |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2016-11-06 |
Detector | MARMOSAIC 225 mm CCD |
Wavelength(s) | 1.0000 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 47.780, 80.370, 114.460 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 41.070 - 2.100 |
R-factor | 0.1675 |
Rwork | 0.165 |
R-free | 0.20550 |
RMSD bond length | 0.008 |
RMSD bond angle | 0.972 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | PHENIX ((1.10.1_2155: ???)) |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 41.070 |
High resolution limit [Å] | 2.100 |
Number of reflections | 26452 |
<I/σ(I)> | 17.1 |
Completeness [%] | 100.0 |
Redundancy | 7.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8 | 293 | 4.5 mg/mL hMesh1 D66K, 50 mM NADPH, 25 mM Tris (pH 8.0), 100 mM NaCl, 0.05% 2-mercaptoethanol, 0.5 mM ZnCl2, 100 mM ammonium acetate, 50 mM sodium citrate, 12.5% PEG 4000. |